Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Stats
Total: 226 #1
CompanyApplied Optoelectronics, Inc.
IndustrySemiconductor - Integrated Circuits
Market Cap221.95MEPS (ttm)-1.63
P/E-EPS this Y-100.50%
Forward P/E-EPS next Y62.10%
PEG-EPS past 5Y33.20%
P/S1.05EPS next 5Y13.00%
P/B0.72EPS Q/Q-242.50%
Dividend-Sales Q/Q-50.60%
Insider Own7.40%Inst Own66.70%
Insider Trans-0.41%Inst Trans-0.05%
Short Float42.15%EarningsNov 06/a
Analyst Recom3.20Target Price10.00
Avg Volume545.40K52W Range8.34 - 23.38
Nov-05-19 03:00PMWhy Rosenblatt is Rooting for AAOI Stock Ahead of Earnings Schaeffer's Investment Research
Nov-01-19 09:07AMWhen Does Market Timing Actually Work? - November 01, 2019 Zacks
Oct-30-19 10:33AMAnalysts Estimate Applied Optoelectronics (AAOI) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-29-19 04:10PMApplied Optoelectronics to Participate in Upcoming Investor Conference GlobeNewswire
Oct-23-19 09:00AMApplied Optoelectronics (AAOI) Upgraded to Buy: Here's Why Zacks
Oct-16-19 08:30AMApplied Optoelectronics to Announce Third Quarter 2019 Financial Results GlobeNewswire
Oct-13-19 08:23AMDoes Applied Optoelectronics (NASDAQ:AAOI) Have A Healthy Balance Sheet? Simply Wall St.
Oct-10-19 07:35AMHow to Time the Markets Like an Investing Pro - October 10, 2019 Zacks
Oct-09-19 08:30AMApplied Optoelectronics, Inc. Announces 400G Transceiver-Switch Interoperability GlobeNewswire
Sep-26-19 08:30AMApplied Optoelectronics Demos Latest Remote PHY Technology at SCTE GlobeNewswire
Applied Optoelectronics, Inc. designs, manufactures, and sells various fiber-optic networking products worldwide. It offers optical modules, lasers, transmitters and transceivers, and turn-key equipment, as well as headend, node, and distribution equipment. The company sells its products to Internet data center operators, cable television and telecommunications equipment manufacturers, and Internet service providers through its direct and indirect sales channels. Applied Optoelectronics, Inc. was founded in 1997 and is headquartered in Sugar Land, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Murry Stefan J.Chief Financial OfficerOct 11Sale10.416,00062,44065,443Oct 15 04:01 PM
Murry Stefan J.Chief Financial OfficerSep 11Option Exercise6.002221,33271,600Sep 13 04:05 PM
Murry Stefan J.Chief Financial OfficerDec 19Sale15.402,00030,80964,520Dec 21 04:05 PM
CompanyACM Research, Inc.
IndustrySemiconductor Equipment & Materials
Market Cap250.41MEPS (ttm)0.67
P/E21.25EPS this Y32.70%
Forward P/E17.41EPS next Y12.50%
PEG1.06EPS past 5Y-
P/S2.68EPS next 5Y20.00%
P/B3.84EPS Q/Q30.60%
Dividend-Sales Q/Q38.80%
Insider Own4.00%Inst Own11.30%
Insider Trans-Inst Trans0.92%
Short Float1.22%EarningsNov 06/a
Analyst Recom1.80Target Price22.60
Avg Volume130.76K52W Range9.02 - 21.88
Nov-05-19 01:34PMHedge Funds Have Never Been This Bullish On ACM Research, Inc. (ACMR) Insider Monkey
Nov-01-19 06:08AMDoes ACM Research's (NASDAQ:ACMR) Share Price Gain of 26% Match Its Business Performance? Simply Wall St.
Oct-24-19 04:05PMACM Research Expands its Global Reach with Senior Sales Team Hires GlobeNewswire
Oct-23-19 09:10AMSimple Market Timing Strategies That Work - October 23, 2019 Zacks
Oct-22-19 04:05PMACM to Release Third Quarter 2019 Financial Results on November 6, 2019 GlobeNewswire
Oct-22-19 10:51AMZacks Industry Outlook Highlights: Cirrus Logic, Alpha and Omega Semiconductor, Silicon Motion Technology and ACM Research Zacks
Oct-21-19 09:23AMOutlook for Electronics Semiconductors Industry Looks Bright Zacks
Sep-26-19 09:45AMHow to Time the Markets Like an Investing Pro - September 26, 2019 Zacks
Sep-26-19 07:08AMWhat Kind Of Shareholder Owns Most ACM Research, Inc. (NASDAQ:ACMR) Stock? Simply Wall St.
Sep-23-19 featured highlights include: ACM Research, GAIN Capital, Cutera, Columbus McKinnon and Minerva Zacks
ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces in a uniform manner on a microscopic level; timely energized bubble oscillation cleaning equipment for two-dimensional and three-dimensional patterned wafers at advanced process nodes; and custom-made wafer assembly and packaging equipment. The company markets and sells its products under the Ultra C brand name through direct sales force and third-party representatives. ACM Research, Inc. was founded in 1998 and is headquartered in Fremont, California.
CompanyAcelRx Pharmaceuticals, Inc.
IndustryMedical Appliances & Equipment
Market Cap158.12MEPS (ttm)-0.72
P/E-EPS this Y-117.40%
Forward P/E-EPS next Y6.70%
PEG-EPS past 5Y-6.50%
P/S71.87EPS next 5Y-
P/B-EPS Q/Q22.60%
Dividend-Sales Q/Q12.50%
Insider Own0.80%Inst Own22.40%
Insider Trans3.32%Inst Trans-0.14%
Short Float19.87%EarningsNov 06/a
Analyst Recom1.90Target Price6.96
Avg Volume776.43K52W Range1.95 - 4.15
Nov-05-19 04:05PMAcelRx Pharmaceuticals to Present at Credit Suisse 28th Annual Healthcare Conference PR Newswire
Oct-30-19 10:33AMEarnings Preview: AcelRx Pharmaceuticals (ACRX) Q3 Earnings Expected to Decline Zacks
Oct-28-19 04:30PMAcelRx to announce third quarter 2019 results and provide an update on the company's business on Wednesday, November 6th, 2019 PR Newswire
Oct-23-19 09:00AMAcelRx Pharmaceuticals (ACRX) Moves to Buy: Rationale Behind the Upgrade Zacks
Oct-16-19 07:00AMDr. TJ Gan to Present at the 2019 Annual Meeting of the American Society of Anesthesiologists PR Newswire
Aug-15-19 04:05PMAcelRx Pharmaceuticals Selected to Present at the 2019 Military Health System Research Symposium PR Newswire
Aug-12-19 07:48AMEdited Transcript of ACRX earnings conference call or presentation 5-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-05-19 09:24PMAcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-05-19 05:35PMAcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Misses Revenue Estimates Zacks
Aug-05-19 04:05PMAcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EDWARDS MARK GDirectorAug 26Buy2.175,00010,850218,750Aug 26 04:52 PM
EDWARDS MARK GDirectorAug 23Buy2.2010,00021,956213,750Aug 26 04:52 PM
Angotti Vincent J.Chief Executive OfficerJun 05Buy2.315,00011,550262,884Jun 06 06:02 AM
EDWARDS MARK GDirectorMar 12Buy2.9919,00056,890200,000Mar 12 02:15 PM
Palmer Pamela PChief Medical OfficerFeb 28Buy2.818402,360541,724Mar 04 04:23 PM
TickerAEL [NYSE]
CompanyAmerican Equity Investment Life Holding Company
IndustryLife Insurance
Market Cap2.39BEPS (ttm)2.31
P/E11.37EPS this Y114.90%
Forward P/E6.50EPS next Y-0.12%
PEG1.14EPS past 5Y8.20%
P/S0.98EPS next 5Y10.00%
P/B0.68EPS Q/Q-80.30%
Dividend1.07%Sales Q/Q3.00%
Insider Own1.50%Inst Own94.50%
Insider Trans-8.22%Inst Trans-0.26%
Short Float1.70%EarningsNov 06/a
Analyst Recom2.70Target Price27.27
Avg Volume445.05K52W Range20.16 - 36.11
Nov-03-19 07:19AMIs It Too Late To Consider Buying American Equity Investment Life Holding Company (NYSE:AEL)? Simply Wall St.
Oct-30-19 10:33AMAnalysts Estimate American Equity Investment (AEL) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-22-19 09:27AMWill American Equity Investment Life Holding Company (AEL) Burn These Hedge Funds? Insider Monkey
Oct-08-19 04:15PMAmerican Equity Schedules Third Quarter 2019 Earnings Release, Conference Call and Webcast Business Wire
Oct-08-19 06:03AMOne Thing To Remember About The American Equity Investment Life Holding Company (NYSE:AEL) Share Price Simply Wall St.
Sep-30-19 11:16AMVoya Financial (VOYA) Up 36% YTD: Will the Rally Continue? Zacks
Sep-26-19 12:24PMPrimerica & Subsidiaries' Ratings Retained by AM Best Zacks
Sep-25-19 08:23AMTop Ranked Momentum Stocks to Buy for September 25th Zacks
Aug-28-19 09:10AMAre Investors Undervaluing American Equity Investment (AEL) Right Now? Zacks
Aug-26-19 01:22PMHere's Why You Should Add Sun Life to Your Portfolio Now Zacks
American Equity Investment Life Holding Company, through its subsidiaries, provides life insurance products and services in the United States. The company issues fixed index and rate annuities; and single premium immediate annuities, as well as life insurance products. It markets its products through independent agents, including national marketing organizations, broker/dealers, banks, and registered investment advisors. The company was founded in 1995 and is headquartered in West Des Moines, Iowa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chapman Joyce AnnDirectorJun 28Sale26.9010,000269,00024,950Jul 01 05:40 PM
Lorenzen Jeffrey DExecutive VP-Chief Inv OfficerJun 28Sale27.2512,413338,25441,030Jul 01 05:42 PM
Johnson Ted MorrisCFO & TreasurerJun 26Sale26.1110,000261,10086,833Jun 27 05:18 PM
Johnson Ted MorrisCFO & TreasurerJun 20Option Exercise9.2710,00092,700106,833Jun 21 01:26 PM
Johnson Ted MorrisCFO & TreasurerJun 20Sale27.5910,000275,85196,833Jun 21 01:26 PM
CompanyAerie Pharmaceuticals, Inc.
IndustryDrug Manufacturers - Major
Market Cap998.06MEPS (ttm)-5.19
P/E-EPS this Y-35.90%
Forward P/E-EPS next Y54.10%
PEG-EPS past 5Y2.60%
P/S20.62EPS next 5Y-
P/B6.94EPS Q/Q26.00%
Dividend-Sales Q/Q558.30%
Insider Own1.50%Inst Own-
Insider Trans153.02%Inst Trans2.91%
Short Float34.63%EarningsNov 06/a
Analyst Recom1.90Target Price56.38
Avg Volume1.29M52W Range17.51 - 56.00
Nov-05-19 06:30AMAerie Pharmaceuticals Announces Positive Topline Results for Netarsudil Ophthalmic Solution in Phase 2 Study Conducted in Japan Business Wire
Oct-30-19 07:30AMAerie Pharmaceuticals to Announce Third Quarter 2019 Financial Results and Host Conference Call on Wednesday, November 6, 2019 Business Wire
Oct-30-19 06:30AMAerie Pharmaceuticals Announces the Appointment of David A. Hollander, M.D., M.B.A., as Chief Research & Development Officer Business Wire
Oct-29-19 10:33AMAerie Pharmaceuticals (AERI) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-28-19 06:13PMIs Aerie Pharmaceuticals Inc (AERI) Going To Burn These Hedge Funds ? Insider Monkey
Oct-25-19 06:40AMImagine Owning Aerie Pharmaceuticals (NASDAQ:AERI) While The Price Tanked 62% Simply Wall St.
Oct-24-19 06:30AMAerie Pharmaceuticals Completes Enrollment in the Phase 2 Trial of AR-1105 (Dexamethasone Intravitreal Implant) in Patients with Macular Edema Associated with Retinal Vein Occlusion Ahead of Schedule Business Wire
Oct-16-19 07:15PMEdited Transcript of AERI earnings conference call or presentation 7-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Oct-07-19 06:30AMAerie Pharmaceuticals Announces Appointment of Charlene E. Davis, Esq., as Vice President and Chief Compliance Officer Business Wire
Sep-25-19 07:30AMAerie Pharmaceuticals to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference Business Wire
Aerie Pharmaceuticals, Inc., an ophthalmic pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma, retinal diseases, and other eye diseases. Its lead product is Rhopressa, a once-daily eye drop to reduce elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension. The company's advanced-stage product candidate is Roclatan, a once-daily eye drop to reduce IOP to treat patients with open-angle glaucoma and ocular hypertension. Aerie Pharmaceuticals, Inc. has a collaborative research, development, and licensing agreement with DSM. Aerie Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANIDO VICENTE JRChief Executive OfficerSep 09Buy19.0126,250498,953197,631Sep 09 05:43 PM
RUBINO RICHARD JChief Financial OfficerSep 09Buy19.935,040100,447339,446Sep 09 05:45 PM
Foresite Capital Management II10% OwnerSep 05Buy18.4215,700289,1942,350,477Sep 06 08:28 PM
Foresite Capital Management II10% OwnerSep 04Buy18.48100,2001,851,6962,334,777Sep 06 08:28 PM
Foresite Capital Management II10% OwnerSep 03Buy20.8150,0001,040,7412,325,477Sep 04 08:38 PM
CompanyAmerican Finance Trust, Inc.
IndustryREIT - Diversified
Market Cap1.55BEPS (ttm)-0.34
P/E-EPS this Y19.10%
Forward P/E12.62EPS next Y8.33%
PEG-EPS past 5Y-12.60%
P/S5.15EPS next 5Y-
P/B0.99EPS Q/Q165.30%
Dividend7.45%Sales Q/Q11.30%
Insider Own0.20%Inst Own33.40%
Insider Trans-Inst Trans-0.19%
Short Float11.05%EarningsNov 06/a
Analyst Recom3.00Target Price13.67
Avg Volume743.81K52W Range9.36 - 15.09
Oct-28-19 12:09PMDid Hedge Funds Drop The Ball On American Finance Trust, Inc. (AFIN) ? Insider Monkey
Oct-28-19 10:23AMIntercontinental (ICE) to Report Q3 Earnings: What's Up? Zacks
Oct-28-19 09:49AMCME Group (CME) to Report Q3 Earnings: What's in the Cards? Zacks
Oct-21-19 06:00AMAmerican Finance Trust Announces Release Date For Third Quarter 2019 Results PR Newswire
Oct-04-19 06:16AMInsider Buying: The American Finance Trust, Inc. (NASDAQ:AFIN) Lead Independent Director Just Bought US$199k Worth Of Shares Simply Wall St.
Oct-01-19 06:00AMAmerican Finance Trust, Inc. Announces Common Stock Dividend for Fourth Quarter 2019 PR Newswire
Sep-24-19 06:00AMAmerican Finance Trust Announces Series A Preferred Stock Dividend PR Newswire
Sep-04-19 09:00AMAmerican Finance Trust Announces Offering of 7.50% Series A Cumulative Redeemable Perpetual Preferred Stock PR Newswire
Sep-03-19 08:56AMKnow This Before Buying American Finance Trust, Inc. (NASDAQ:AFIN) For Its Dividend Simply Wall St.
Aug-09-19 12:09PMAmerican Finance Trust, Inc (AFIN) Q2 2019 Earnings Call Transcript Motley Fool
American Finance Trust, Inc. (Nasdaq: AFIN) is a publicly traded real estate investment trust listed on the Nasdaq focused on acquiring and managing a diversified portfolio of primarily service-oriented and traditional retail and distribution related commercial real estate properties in the U.S.
CompanyAimmune Therapeutics, Inc.
Market Cap1.75BEPS (ttm)-3.72
P/E-EPS this Y-77.20%
Forward P/E-EPS next Y11.70%
PEG-EPS past 5Y-
P/S-EPS next 5Y34.60%
P/B8.82EPS Q/Q-11.10%
Dividend-Sales Q/Q-
Insider Own0.40%Inst Own88.50%
Insider Trans0.65%Inst Trans0.90%
Short Float25.48%EarningsNov 06/a
Analyst Recom2.00Target Price48.00
Avg Volume1.07M52W Range16.95 - 36.12
Nov-04-19 04:05PMAimmune to Participate in the Credit Suisse 28th Annual Healthcare Conference Business Wire
Oct-31-19 07:00AMAimmune to Present New Data on Safety and Efficacy of AR101, Clinical Practice Implementation of Oral Immunotherapy, Quality of Life and Other Related Studies at ACAAI 2019 Business Wire
Oct-30-19 07:00AMAimmune Therapeutics to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results and Recent Operational Highlights Business Wire
Oct-28-19 10:59AMHere is What Hedge Funds Think About Aimmune Therapeutics Inc (AIMT) Insider Monkey
Oct-24-19 04:55PMNajarian Brothers Highlight Unusual Options Activity In Activision Blizzard, Cronos Group Benzinga
Oct-07-19 06:48AMMy Stock of the Week Is Aimmune Therapeutics
Oct-03-19 01:24AMEdited Transcript of AIMT earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-26-19 07:00AMAimmune to Present at the Cantor Global Healthcare Conference Business Wire
Sep-18-19 10:33AMBiotech Stock Roundup: BIIB Halts AD Study, AMGN Posts Positive MM Drug Data & More Zacks
Sep-16-19 04:19PMAnalyst: DBV's Peanut Allergy Drug Could Outscore Aimmune's On Safety Front Benzinga
Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes product candidates for the treatment of peanut and other food allergies. Its lead Characterized Oral Desensitization ImmunoTherapy (CODIT) product candidate is AR101, an investigational biologic, which is in Phase III clinical trial for the treatment of patients with peanut allergy. The company also engages in the research and development of AR201, a CODIT product candidate for the treatment of egg allergy in pediatric and young adult patients; and other CODIT product candidates targeting food allergies, such as cow's milk allergy. Aimmune Therapeutics, Inc. has a strategic collaboration with an affiliate of Nestle Health Science US Holdings, Inc. for the advancement of food allergy therapeutics; and clinical collaboration agreement with Regeneron Ireland Unlimited Company and Sanofi Biotechnology SAS to study AR101 with adjunctive dupilumab in peanut-allergic patients in a Phase II trial. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. in May 2015. Aimmune Therapeutics, Inc. was founded in 2011 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BJERKHOLT ERICChief Financial OfficerSep 18Buy22.571,55034,97733,574Sep 20 08:55 AM
Barrowcliffe Susan E.General Manager, EuropeNov 19Option Exercise3.0240,000120,88049,375Nov 21 04:05 PM
Dallas Jayson Donald AlexanderPresident and CEONov 19Buy27.563,650100,58763,650Nov 19 08:12 PM
Barrowcliffe Susan E.General Manager, EuropeNov 19Sale30.0440,0001,201,6009,375Nov 21 04:05 PM
TickerALB [NYSE, S&P 500]
CompanyAlbemarle Corporation
IndustrySpecialty Chemicals
Market Cap7.14BEPS (ttm)4.95
P/E13.62EPS this Y45.40%
Forward P/E11.27EPS next Y-2.58%
PEG1.23EPS past 5Y4.80%
P/S2.09EPS next 5Y11.10%
P/B1.88EPS Q/Q-46.90%
Dividend2.18%Sales Q/Q3.70%
Insider Own0.40%Inst Own96.30%
Insider Trans-7.00%Inst Trans0.03%
Short Float17.21%EarningsNov 06/a
Analyst Recom2.40Target Price77.08
Avg Volume1.63M52W Range58.63 - 108.74
Nov-06-19 09:36AMNew Strong Sell Stocks for November 6th Zacks
Nov-04-19 11:02AMLithium Stocks Look Poised to Charge Higher Investopedia
Nov-04-19 06:59AMAlbemarle (ALB) to Report Q3 Earnings: What's in the Offing? Zacks
Nov-02-19 09:21AMHere's What Albemarle Corporation's (NYSE:ALB) P/E Ratio Is Telling Us Simply Wall St.
Nov-01-19 11:59PM5 Stocks That Should Gain From the Falling Cost of Renewable Energy
Oct-31-19 06:53PMAlbemarle Announces Completion of Lithium Joint Venture with Mineral Resources Limited PR Newswire
Oct-31-19 09:04AM4 Stocks in Focus on Electric Vehicle Revolution Zacks
Oct-30-19 10:33AMAlbemarle (ALB) Earnings Expected to Grow: Should You Buy? Zacks
Oct-29-19 12:41PMJim Cramer Weighs In On Wendy's, CME Group And More Benzinga
Oct-29-19 11:58AMUPDATE 1-LME to launch lithium committee including Tesla, Albemarle Reuters
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The company's Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Catalysts segment offers performance catalyst solutions comprising hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was incorporated in 1993 and is headquartered in Charlotte, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KISSAM LUTHER C IVChairman, President & CEOSep 13Option Exercise41.9436,0001,509,840334,046Sep 17 04:32 PM
KISSAM LUTHER C IVChairman, President & CEOSep 13Sale70.0036,0002,520,000298,046Sep 17 04:32 PM
Norris EricPresident, LithiumAug 20Buy64.663,090199,7903,090Aug 20 04:31 PM
Johnson Netha N.President, Bromine SpecialtiesAug 09Option Exercise0.003,30903,309Aug 13 04:38 PM
Marlow DeeAnne JSVP, Chief HR OfficerMay 13Buy70.851,00070,8501,000May 15 04:52 PM
CompanyANGI Homeservices Inc.
IndustryInternet Software & Services
Market Cap3.33BEPS (ttm)0.15
P/E43.70EPS this Y147.60%
Forward P/E58.02EPS next Y43.21%
PEG-EPS past 5Y17.80%
P/S2.71EPS next 5Y-
P/B2.55EPS Q/Q-70.30%
Dividend-Sales Q/Q16.70%
Insider Own1.10%Inst Own88.80%
Insider Trans0.00%Inst Trans-0.24%
Short Float26.45%EarningsNov 06/a
Analyst Recom2.20Target Price11.78
Avg Volume2.18M52W Range6.51 - 22.83
Oct-30-19 10:33AMEarnings Preview: ANGI Homeservices (ANGI) Q3 Earnings Expected to Decline Zacks
Oct-30-19 10:14AMNextdoor CEO: Here's why we see Denver as one of the company's top markets American City Business Journals
Oct-29-19 02:30PMHomeAdvisor Launches Homeservices Capsule In Samsung's Bixby Marketplace PR Newswire
Oct-26-19 08:27AMDoes ANGI Homeservices Inc. (NASDAQ:ANGI) Have A Volatile Share Price? Simply Wall St.
Oct-25-19 09:27AMSee where the 25 highest-paid Colorado CEOs went to college (Photos) American City Business Journals
Oct-16-19 04:05PMANGI Homeservices to Announce Q3 2019 Earnings on November 6th and Host Earnings Conference Call on November 7th GlobeNewswire
Oct-15-19 01:05PMAnalysts: Match Spinoff Should Be Good For IAC Benzinga
Oct-14-19 08:55PMIs ANGI Homeservices Inc. (ANGI) Going to Burn These Hedge Funds? Insider Monkey
Oct-11-19 11:24AMANGI stock gains as IAC update on spinoff provides 'comfort' that company will still get support MarketWatch
Oct-11-19 11:05AMIAC Stock Climbs on Plan to Spin Off Match Stock to Holders
ANGI Homeservices Inc. operates a digital marketplace for home services, connecting millions of homeowners with home service professionals in North America and Europe. Its HomeAdvisor digital marketplace service connects consumers with service professionals for home repair, maintenance, and improvement projects, as well as provides consumers with tools and resources to help them find local, pre-screened, and customer-rated service professionals. The company also owns and operates Angie's List, which connects consumers with service professionals for local services through an online directory of service professionals in various service categories; and provides consumers with valuable tools, services, and content, including verified reviews, to help them research, shop, and hire for local services. In addition, it operates Handy, a platform for connecting individuals looking for household services, primarily cleaning and handyman services; mHelpDesk and CraftJack service brands; HomeStars, a home services platform; and home services online marketplaces, including Travaux, MyHammer, Werkspot, MyBuilder, Instapro, and MyHammer. The company was formerly known as Halo TopCo, Inc. and changed its name to ANGI Homeservices Inc. in May 2017. ANGI Homeservices Inc. was incorporated in 2017 and is headquartered in Denver, Colorado. ANGI Homeservices Inc. is a subsidiary of IAC/InterActiveCorp.
TickerANSS [NASD, S&P 500]
CompanyANSYS, Inc.
IndustryApplication Software
Market Cap18.34BEPS (ttm)5.10
P/E42.77EPS this Y54.40%
Forward P/E31.93EPS next Y9.41%
PEG6.11EPS past 5Y13.70%
P/S13.19EPS next 5Y7.00%
P/B6.50EPS Q/Q18.70%
Dividend-Sales Q/Q20.50%
Insider Own0.90%Inst Own98.25%
Insider Trans-0.71%Inst Trans3.70%
Short Float2.22%EarningsNov 06/a
Analyst Recom2.20Target Price225.77
Avg Volume470.72K52W Range136.80 - 229.20
Nov-05-19 10:30AMTech Stocks' Earnings Roster for Nov 6: SQ, ANSS, GIB & More Zacks
Nov-04-19 12:01PMANSYS To Extend Microsoft Azure Digital Twins With Physics-Based Simulations PR Newswire
Nov-04-19 08:57AMANSYS (ANSS) Gears Up for Q3 Earnings: What's in Store? Zacks
Oct-31-19 07:00AMCarnegie Mellon University and ANSYS Transform Engineering Education and Research to Spur Next Industrial Revolution PR Newswire
Oct-30-19 10:33AMAnalysts Estimate Ansys (ANSS) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-25-19 02:31PMDoes ANSYS, Inc.'s (NASDAQ:ANSS) CEO Pay Reflect Performance? Simply Wall St.
Oct-24-19 07:05AMANSYS and Simulation Process Integration and Design Optimization Leader Dynardo Sign Definitive Acquisition Agreement PR Newswire
Oct-23-19 07:00AMASE Group Significantly Advances Semiconductor Packaging Development With ANSYS Customization Toolkit Solution PR Newswire
Oct-17-19 07:00AMSamsung Foundry Certifies ANSYS Multiphysics Simulation Solutions For Multi-Die Integration Advanced Packaging Technology PR Newswire
Oct-16-19 11:24AMANSYS Helps TURBOTECH to Develop Hybrid-Electric Aircraft Zacks
ANSYS, Inc. develops and markets engineering simulation software and services worldwide. The company offers ANSYS Workbench, a framework upon which the company's engineering simulation technologies are built; ANSYS multiphysics software to simulate the interactions between structures, heat transfer, fluids, and electronics in a unified engineering simulation environment; and structural analysis product suite that provides simulation tools for product design and optimization. It also provides fluids product suite that enables modeling of fluid flow and other related physical phenomena; and electromagnetics product suite, which provides field simulation software for designing electronic. In addition, the company offers power analysis and optimization software suite that manages the power budget, power delivery integrity, and power-induced noise in an electronic design; SCADE product suite, a solution for embedded software simulation, code production, and automated certification; system simulation capability for the design of automated products; and high-performance computing product suite, which delivers cross-physics parallel processing capabilities for simulation software. Further, it provides Discovery product family for use in the simulation of product design; academic product suite with a portfolio of academic products based on associate, research, and teaching; ANSYS Fluent that enhance workflow process; and ANSYS medini analyze, a suite for functional safety analysis. The company serves engineers, designers, researchers, and students in the aerospace and defense, automotive, electronics, semiconductors, energy, materials and chemical processing, turbomachinery, consumer products, healthcare, and sports industries and academia. ANSYS, Inc. was founded in 1970 and is headquartered in Canonsburg, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEE JANETVP, General CounselSep 23Sale215.261,174252,71513,546Sep 24 08:19 PM
MAHONEY RICHARD S.VP, WORLDWIDE SALES & SUPPORTAug 08Sale210.479720,41630,782Aug 09 06:00 PM
McDermott William RDirectorMay 24Sale181.531,765320,40038,445May 28 06:30 PM
SCHERER BARBARA VAUGHNDirectorMay 21Sale186.201,765328,63713,336May 23 06:30 PM
GALLIMORE ALEC D.DirectorMay 21Sale185.78638118,5283,262May 23 06:30 PM
1 2 3 4 5 6 ... 10 ... 20 ... 23 next